|Synonyms||4-Oxoisotretinoin; Ro 22-6595|
|Purity Chemicals||≥98% (HPLC)|
|Appearance||Dark yellow powder.|
|Solubility||Soluble in acetone, chloroform, ethanol (slightly) or ether.|
|Identity||Determined by NMR.|
|Declaration||Manufactured by Chemodex.|
|Other Product Data||
Click here for Original Manufacturer Product Datasheet
|Shipping and Handling|
|Short Term Storage||+4°C|
|Long Term Storage||-20°C|
Keep cool and dry.
Protect from light and moisture.
|Use/Stability||Stable for at least 2 years after receipt when stored at -20°C.|
|Product Specification Sheet|
Mayor active metabolites of 13-cis-retinoic acid (important drug in dermatology and treatment of neuroblastoma) with effects on gene transcription that regulate growth, differentiation and inflammation in normal and neoplastic skin cells. Shown to be as active as 13-cis-retinoic acid against neuroblastoma cell lines. Can be used as reference compound.
(1) F.M. Vane & C.J. Bugge; Drug Metab. Dispos. 9, 515 (1981) | (2) J.M. Baron, et al.; J. Invest. Derm. 125, 143 (2005) | (3) S.E. Rowbotham, et al.; DMD 38, 1211 (2010) | (4) P. Sonawane, et al.; Br. J. Pharmacol. 171, 5330 (2014)